Cargando…

Tumour budding and its clinical implications in gastrointestinal cancers

Tumour budding in colorectal cancer has become an important prognostic factor. Represented by single cells or small tumour cell clusters at the invasion front of the tumour mass, these tumour buds seem to reflect cells in a ‘hybrid’ state of epithelial–mesenchymal transition, and evidence indicates...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zlobec, Inti, Berger, Martin D., Lugli, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462864/ https://www.ncbi.nlm.nih.gov/pubmed/32601463 http://dx.doi.org/10.1038/s41416-020-0954-z

Ejemplares similares

Tumor Budding in Upper Gastrointestinal Carcinomas
por: Koelzer, Viktor H., et al.
Publicado: (2014)

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget
por: Zlobec, Inti, et al.
Publicado: (2010)

Role of Intra- and Peritumoral Budding in the Interdisciplinary Management of Rectal Cancer Patients
por: Zlobec, Inti, et al.
Publicado: (2012)

Refining the ITBCC tumor budding scoring system with a “zero-budding” category in colorectal cancer
por: Zlobec, Inti, et al.
Publicado: (2021)

Tumour budding: a promising parameter in colorectal cancer
por: Lugli, A, et al.
Publicado: (2012)

Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining
por: Blank, Annika, et al.
Publicado: (2019)

Cytokeratin‐based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience
por: Koelzer, Viktor H, et al.
Publicado: (2017)

The battle for prognosis at the invasive front of colorectal cancer
por: Lugli, Alessandro, et al.
Publicado: (2020)

DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells
por: Ivanovska, Jelena, et al.
Publicado: (2015)

Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
por: Karamitopoulou, Eva, et al.
Publicado: (2013)

Cell Line Derived Xenograft Mouse Models Are a Suitable in vivo Model for Studying Tumor Budding in Colorectal Cancer
por: Georges, Laurent M. C., et al.
Publicado: (2019)

Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data
por: Trinh, Anne, et al.
Publicado: (2018)

Correction: DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells
por: Ivanovska, Jelena, et al.
Publicado: (2017)

Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma
por: Wartenberg, Martin, et al.
Publicado: (2015)

TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer
por: Galván, José A., et al.
Publicado: (2014)

Semi-Supervised Learning to Automate Tumor Bud Detection in Cytokeratin-Stained Whole-Slide Images of Colorectal Cancer
por: Bokhorst, John-Melle, et al.
Publicado: (2023)

Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing
por: Bihl, Michel P, et al.
Publicado: (2012)

Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer
por: Eppenberger, Manuela, et al.
Publicado: (2010)

Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
por: Galván, J A, et al.
Publicado: (2015)

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer
por: Lugli, A, et al.
Publicado: (2009)

A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
por: Zlobec, Inti, et al.
Publicado: (2014)

LAG-3 Expression Predicts Outcome in Stage II Colon Cancer
por: Rhyner Agocs, Gaëlle, et al.
Publicado: (2021)

Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree?
por: Blank, Annika, et al.
Publicado: (2018)

High tumor budding stratifies breast cancer with metastatic properties
por: Salhia, Bodour, et al.
Publicado: (2015)

Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study
por: Koelzer, Viktor H, et al.
Publicado: (2015)

Stratification and Prognostic Relevance of Jass’s Molecular Classification of Colorectal Cancer
por: Zlobec, Inti, et al.
Publicado: (2012)

Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer
por: Sokol, Lena, et al.
Publicado: (2015)

Role of tumor size in the pre-operative management of rectal cancer patients
por: Zlobec, Inti, et al.
Publicado: (2010)

Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types
por: Zlobec, Inti, et al.
Publicado: (2013)

Classification of colorectal tissue images from high throughput tissue microarrays by ensemble deep learning methods
por: Nguyen, Huu-Giao, et al.
Publicado: (2021)

Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer
por: Rogers, A C, et al.
Publicado: (2016)

A Digital Pathology-Based Shotgun-Proteomics Approach to Biomarker Discovery in Colorectal Cancer
por: Zahnd, Stefan, et al.
Publicado: (2019)

Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer
por: Nguyen, Huu-Giao, et al.
Publicado: (2021)

A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer
por: Noti, Luca, et al.
Publicado: (2022)

Molecular and Pathogenetic Aspects of Tumor Budding in Colorectal Cancer
por: Dawson, Heather, et al.
Publicado: (2015)

Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study
por: Karamitopoulou, Eva, et al.
Publicado: (2020)

Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer
por: Dawson, Heather, et al.
Publicado: (2013)

Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients
por: Zlobec, I, et al.
Publicado: (2014)

Immunophenotypic profile of tumor buds in breast cancer
por: Laedrach, C., et al.
Publicado: (2017)

Improving tumor budding reporting in colorectal cancer: a Delphi consensus study
por: Haddad, Tariq Sami, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mkmubqtvr5po9ki8tbgkdb6rf4